Conversely, downregulated genes in T-SCLC included KRT16P2, EREG, B3GNT3, which are mainly enriched in immune-related pathways, such as T/B cell receptor signalling pathway the antigen processing and presentation pathway (Fig. 1B and C). The gene discussed is B3GNT3; the disease is small cell lung carcinoma.